Dial Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 24-10-2024
- Paid Up Capital ₹ 5.00 M
as on 24-10-2024
- Company Age 21 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 10.38 Cr
as on 24-10-2024
- Satisfied Charges ₹ 5.68 Cr
as on 24-10-2024
- Revenue 6.21%
(FY 2023)
- Profit 141.41%
(FY 2023)
- Ebitda 20.65%
(FY 2023)
- Net Worth 130.85%
(FY 2023)
- Total Assets -16.20%
(FY 2023)
About Dial Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹10.38 Cr. The company has closed loans amounting to ₹5.68 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sanjay Sheth, Rannaben Sheth, and Bindiben Sheth serve as directors at the Company.
- CIN/LLPIN
U24231GJ2003PTC042823
- Company No.
042823
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Sep 2003
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Dial Pharmaceuticals Private Limited offer?
Dial Pharmaceuticals Private Limited offers a wide range of products and services, including Skin Care, Bath Essentials.
Who are the key members and board of directors at Dial Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rannaben Sheth  | Director | 01-Sep-2003 | Current |
| Sanjay Sheth | Director | 01-Sep-2003 | Current |
| Bindiben Sheth | Director | 01-Sep-2003 | Current |
Financial Performance of Dial Pharmaceuticals.
Dial Pharmaceuticals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.21% increase. The company also saw a substantial improvement in profitability, with a 141.41% increase in profit. The company's net worth Soared by an impressive increase of 130.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dial Pharmaceuticals?
Unlock access to Dial Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 27 Nov 2020 | ₹2.90 Cr | Open |
Others Creation Date: 17 Dec 2019 | ₹7.48 Cr | Open |
Sidbi Creation Date: 16 Jun 2020 | ₹5.00 M | Satisfied |
How Many Employees Work at Dial Pharmaceuticals?
Dial Pharmaceuticals has a workforce of 19 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dial Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dial Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
